DISSOCIATION OF RELAXIN AND PROGESTERONE SECRETION FROM THE PRIMATE CORPUS-LUTEUM BY ACUTE ADMINISTRATION OF A 3-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITOR DURING THE MENSTRUAL-CYCLE
Dm. Duffy et al., DISSOCIATION OF RELAXIN AND PROGESTERONE SECRETION FROM THE PRIMATE CORPUS-LUTEUM BY ACUTE ADMINISTRATION OF A 3-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITOR DURING THE MENSTRUAL-CYCLE, Biology of reproduction, 53(2), 1995, pp. 447-453
The factors regulating relaxin production by the primate CL during spo
ntaneous menstrual cycles and in early pregnancy are poorly understood
, Since the CL produces steroids, notably progesterone, and expresses
progesterone receptors, luteal progesterone may act locally to regulat
e relaxin production, For the current study, either trilostane (600 mg
daily)-a 3 beta-hydroxysteroid dehydrogenase inhibitor-or vehicle was
administered to rhesus monkeys during the midluteal phase (Days 6 and
7) of spontaneous menstrual cycles to examine the effects of reduced
luteal progesterone synthesis on relaxin secretion, Trilostane treatme
nt reduced serum concentrations of progesterone within 3 h of initial
administration and maintained low levels typical of the follicular pha
se (< 1 ng/ml), causing premature menses without significant alteratio
n in serum bioactive LH levels. Nevertheless, the patterns and levels
of circulating relaxin, as measured by homologous macaque ELISA, were
not different between trilostane- and vehicle-treated monkeys, with re
laxin levels peaking in both groups by Day 13 of the luteal phase, To
determine if chorionic gonadotropin (CG) injections simulating early p
regnancy could stimulate relaxin production in a progesterone-depleted
environment, trilostane or vehicle was administered as described abov
e, followed by injections in increasing dosages of human (h) CG beginn
ing 3 days after initial trilostane administration. Serum progesterone
levels in trilostane-treated animals were significantly reduced prior
to and during hCG treatment when compared with vehicle-treated animal
s. However, serum relaxin levels were comparable between these groups;
relaxin levels peaked approximately 10-fold above pre-hCG levels in b
oth trilostane- and vehicle-treated animals, These data indicate that
serum relaxin levels similar to those observed in control monkeys can
be maintained during a period of very low progesterone concentrations
during the spontaneous menstrual cycle and that even in a progesterone
-depleted environment, CG remains an effective stimulator of relaxin p
roduction. Therefore, it is unlikely that progesterone acts locally to
promote the production and release of relaxin from the primate CL dur
ing the menstrual cycle or early pregnancy.